Company: CDT
Filing Date: 2025-07-08
Form Type: DEF 14A
Source: 0001641172-25-018242
Chunk: 2

Company: CDT Equity Inc.
Filing Date: 2025-07-08
Form: DEF 14A
Chunk 2
---
://ts.vstocktransfer.com/irhlogin/I-CONDUIT</div>

<div align='center'>TABLE OF CONTENTS</div>

| PROXY STATEMENT                                                                                                                                               |  1 |
| PROPOSAL NO. 1 – ELECTION OF DIRECTORS                                                                                                                        |  6 |
| DIRECTORS’ NOMINATION                                                                                                                                         |  9 |
| DIRECTORS’ COMPENSATION                                                                                                                                       | 10 |
| CORPORATE GOVERNANCE                                                                                                                                          | 12 |
| EXECUTIVE COMPENSATION                                                                                                                                        | 16 |
| EQUITY COMPENSATION PLAN INFORMATION                                                                                                                          | 22 |
| TRANSACTIONS WITH RELATED PERSONS                                                                                                                             | 23 |
| REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS                                                                                                       | 29 |
| SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT                                                                                                | 30 |
| PROPOSAL NO. 2 – RATIFICATION OF THE APPOINTMENT OF OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM                                                         | 32 |
| PROPOSAL NO. 3 – APPROVAL OF AN INCREASE IN THE NUMBER OF SHARES ISSUABLE PURSUANT TO THE 2023 PLAN, IN THE FORM ATTACHED AS ANNEX A TO THIS PROXY STATEMENT. | 34 |
| DELINQUENT SECTION 16(a) REPORTS                                                                                                                              | 44 |
| ANNUAL REPORT TO STOCKHOLDERS                                                                                                                                 | 44 |
| STOCKHOLDER PROPOSALS                                                                                                                                         | 44 |
| OTHER MATTERS                                                                                                                                                 | 45 |

| i |

<div align='center'>4581 Tamiami Trail North, Suite 200

Naples, FL 34103

(646) 491-9132

PROXY STATEMENT</div>

Conduit Pharmaceuticals Inc. is furnishing this proxy statement to our stockholders of record as of the close of business on July 3, 2025 (the “Record Date”) in connection with our solicitation of proxies for use at the virtual annual meeting of stockholders to be held on Tuesday, August 5, 2025 at 10:00 a.m., Eastern Time and any adjournment(s), postponement(s) or other delays thereof (the “2025 Annual Meeting”).

The 2025 Annual Meeting will be a completely “virtual” meeting of stockholders. You will be able to listen and participate in the virtual annual meeting as well as vote and submit your questions during the live